SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326190-24-000050
Filing Date
2024-11-12
Accepted
2024-11-12 16:06:54
Documents
59
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20240930x10q.htm   iXBRL 10-Q 1256739
2 EX-31.1 alt-20240930xex31d1.htm EX-31.1 11941
3 EX-31.2 alt-20240930xex31d2.htm EX-31.2 11763
4 EX-32.1 alt-20240930xex32d1.htm EX-32.1 6761
5 EX-32.2 alt-20240930xex32d2.htm EX-32.2 6870
6 GRAPHIC alt-20240930x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001326190-24-000050.txt   5188685

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20240930.xsd EX-101.SCH 34134
8 EX-101.CAL alt-20240930_cal.xml EX-101.CAL 43553
9 EX-101.DEF alt-20240930_def.xml EX-101.DEF 114646
10 EX-101.LAB alt-20240930_lab.xml EX-101.LAB 344515
11 EX-101.PRE alt-20240930_pre.xml EX-101.PRE 227880
62 EXTRACTED XBRL INSTANCE DOCUMENT alt-20240930x10q_htm.xml XML 778624
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 241448046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)